AM
Asaf Muhamed Nechikkadan
About Asaf Muhamed Nechikkadan
Asaf Muhamed Nechikkadan has 15 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Flor Diagnostics Private Limited and Alkhaleej Super Speciality Hospital Private Limited. Formerly with 1 company, such as Eram Scientific Solutions Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Flor Diagnostics Private Limited
U51909KL2020PTC062214
|
Director | 01 Jun 2020 | 2020 | Active |
Alkhaleej Super Speciality Hospital Private Limited
U85120KL2012PTC031913
|
Additional Director | 02 Dec 2019 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Eram Scientific Solutions Private Limited
U72200KL2008PTC023199
|
Director | 06 Jul 2011 | 2008 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Asaf Muhamed Nechikkadan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asaf Muhamed Nechikkadan
Asaf Muhamed Nechikkadan has 15 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Flor Diagnostics Private Limited and Alkhaleej Super Speciality Hospital Private Limited. Formerly with 1 company, such as Eram Scientific Solutions Private Limited. Engaged in General Business. Contributes to corporate operations.
Asaf Muhamed Nechikkadan is associated with 2 companies as Director and Additional Director.
Asaf Muhamed Nechikkadan has expertise in General Business.
Asaf Muhamed Nechikkadan has 15 years in corporate governance.